Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival

Background: This study reports the results of hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone (dex) in patients with unresectable intrahepatic cholangiocarcinoma (ICC) or hepatocellular carcinoma (HCC) and investigates dynamic contrast-enhanced magnetic resonance imaging (D...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Jarnagin, W. R., Schwartz, L. H., Gultekin, D. H., Gönen, M., Haviland, D., Shia, J., D'Angelica, M., Fong, Y., DeMatteo, R., Tse, A., Blumgart, L. H., Kemeny, N.
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2009
Assuntos:
Original Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2731015/
https://ncbi.nlm.nih.gov/pubmed/19491285
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdp029
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares